Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie's JAK-1 inhibitor hits the mark in Crohn's disease
AbbVie's JAK-1 inhibitor hits the mark in Crohn's disease
AbbVie's JAK-1 inhibitor hits the mark in Crohn's disease
Submitted by
admin
on May 11, 2017 - 11:17am
Source:
BioPharma Dive
News Tags:
AbbVie
JAK inhibitors
Crohn's Disease
Upadacitinib
Headline:
AbbVie's JAK-1 inhibitor hits the mark in Crohn's disease
Do Not Allow Advertisers to Use My Personal information
